. Author manuscript; available in PMC: 2013 Jul 5.

Published in final edited form as: Leuk Lymphoma. 2008 Apr;49(4):690–695. doi: 10.1080/10428190701882146

Table 3.

Characteristics of Responders

	No. prior Aza courses	Best response Aza	Reason off Aza/Weeks off Aza	Weeks from prior Aza before DAC	Best response DAC/Courses to response	Response Duration (months)	Percent marrow Blasts Pre/at response	Platelets Pre/at response	ANC Pre/at response
1	8	Marrow CR	PD	3	CR/3	9.7	15/1	24/336	1.1/3.2
2	4	SD	NR	11	Marrow CR/3	8.2	8/4	65/95	1.8/5.1
3	4	SD	NR	9	CR/5	11.3+	12/3	80/234	0.6-1.4
4	1	N/A	Toxicity	5	CR/1	10.2	13/4	24/110	0.38/2.8

Abbreviations: CR= complete remission, Aza= azacitidine, DAC= decitabine, SD=stable disease, PD= progressive disease, NR= no response, ANC= absolute neutrophil count